NASDAQ : HQY
HealthEquity, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 102.47 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.48B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 8.48B |
| Enterprise Value | 9.19B |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 82.72M |
| Shares Outstanding | 82.72M |
| Shares Change (YoY) | -3.29% |
| Shares Change (QoQ) | -1.17% |
| Owned by Insiders (%) | 2.07% |
| Owned by Institutions (%) | 110.12% |
| Float | 80.97M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 37.08 |
| Forward PE | 20.24 |
| PS Ratio | 6.22 |
| Forward PS | 5.76 |
| PB Ratio | 4.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 17.38 |
| P/OCF Ratio | 17.29 |
| PEG Ratio | 1.26 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 38.86 |
| EV / Sales | 6.75 |
| EV / EBITDA | 17.89 |
| EV / EBIT | 25.82 |
| EV / FCF | 18.84 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.99 |
| Quick Ratio | 2.46 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 1.88 |
| Debt / FCF | 1.99 |
| Interest Coverage | 6.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.43% |
| Return on Assets (ROA) | 6.65% |
| Return on Invested Capital (ROIC) | 9.97% |
| Return on Capital Employed (ROCE) | 11.42% |
| Weighted Average Cost of Capital (WACC) | 5.43% |
| Revenue Per Employee | $484,052 |
| Profits Per Employee | $84,042 |
| Employee Count | 2,814 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 72.22M |
| Effective Tax Rate | 23.39% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +8.50% |
| 50-Day Moving Average | 95.37 |
| 200-Day Moving Average | 89.01 |
| Relative Strength Index (RSI) | 66.33 |
| Average Volume (20 Days) | 758,145 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.94M |
| Short Previous Month | 5.99M |
| Short % of Shares Out | 7.19% |
| Short % of Float | 7.34% |
| Short Ratio (days to cover) | 6.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.36B |
| Gross Profit | 970.48M |
| Operating Income | 355.98M |
| Pretax Income | 308.71M |
| Net Income | 236.49M |
| EBITDA | 513.61M |
| EBIT | 355.98M |
| Earnings Per Share (EPS) | $2.76 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 256.00M |
| Total Debt | 971.02M |
| Net Cash | -715.01M |
| Net Cash Per Share | -$8.64 |
| Equity (Book Value) | 1.99B |
| Book Value Per Share | 24.00 |
| Working Capital | 306.43M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 490.18M |
| Capital Expenditures | -2.45M |
| Depreciation & Amortization | 157.63M |
| Net Borrowing | -76.88M |
| Free Cash Flow | 487.73M |
| FCF Per Share | $5.90 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.25% |
| Operating Margin | 26.13% |
| Pretax Margin | 22.66% |
| Profit Margin | 17.36% |
| EBITDA Margin | 37.71% |
| EBIT Margin | 26.13% |
| FCF Margin | 35.81% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.29% |
| Shareholder Yield | 3.29% |
| Earnings Yield | 2.70% |
| FCF Yield | 5.75% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $120.67 |
| Price Target Difference | 17.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 6.94% |
| EPS Growth Forecast (3Y) | 13.62% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.51 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |